NCT04512430 2025-04-02
Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients
Fundación GECP
Phase 2 Terminated
Fundación GECP
University of California, San Francisco
SCRI Development Innovations, LLC
Barbara Ann Karmanos Cancer Institute
Holy Cross Hospital, Florida
Rutgers, The State University of New Jersey
Pharmatech
Northwestern University